HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fumiyo Fukuya Selected Research

BS 1417

7/2005A Novel alphavbeta3 integrin antagonist suppresses neointima formation for more than 4 weeks after balloon injury in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Fumiyo Fukuya Research Topics

Disease

2Neointima
07/2005 - 05/2004

Drug/Important Bio-Agent (IBA)

1BS 1417IBA
07/2005
1Integrin alphaVbeta3IBA
07/2005
1Integrin beta3 (GPIIIa)IBA
05/2004

Therapy/Procedure

1Subcutaneous Infusions
07/2005